Tomic, Kresimir, et al., reported that the median time to T-SCLC transformation in EGFR-mutant NSCLC patients treated with TKIs is approximately 17 months, with a median overall survival of 10 months (28). This evidence concerns the gene EGFR and non-small cell lung carcinoma.